Market Cap 16.36B
Revenue (ttm) 2.33B
Net Income (ttm) 984.80M
EPS (ttm) N/A
PE Ratio 16.03
Forward PE 12.73
Profit Margin 42.31%
Debt to Equity Ratio 0.07
Volume 248,300
Avg Vol 323,026
Day's Range N/A - N/A
Shares Out 44.65M
Stochastic %K 69%
Beta 0.57
Analysts Strong Sell
Price Target $399.62

Latest News on UTHR

The Zen Ten - My Top Picks For 2025

Dec 29, 2024, 4:25 PM EST - 20 days ago

The Zen Ten - My Top Picks For 2025

AAPL BBW IBKR INTU META NVDA TSM


United Therapeutics Shares Thrive

Aug 30, 2024, 12:02 PM EDT - 5 months ago

United Therapeutics Shares Thrive


United Therapeutics: Economics Support Compounding Ability

Aug 19, 2024, 10:00 PM EDT - 5 months ago

United Therapeutics: Economics Support Compounding Ability


Big Money Elevating United Therapeutics

Jun 28, 2024, 10:36 AM EDT - 7 months ago

Big Money Elevating United Therapeutics


United Therapeutics to Acquire Miromatrix Medical.

Oct 30, 2023, 6:05 AM EDT - 1 year ago

United Therapeutics to Acquire Miromatrix Medical.

MIRO